Back
CRISPR Therapeutics AG Stock Predictions
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Sell
11
CRSP
CRISPR Therapeutics AG
Last Price:
$40.51
Seasonality Move:
0.72%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]CRISPR Therapeutics AG Stock Forecast
-
Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 32.5% based on the past 8 years of stock performance.
-
CRISPR Therapeutics AG has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
-
Is CRISPR Therapeutics AG Stock Undervalued?The current CRISPR Therapeutics AG [CRSP] share price is $40.53. The Score for CRSP is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will CRISPR Therapeutics AG Stock Go Up Next Year?
-
Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 32.5% based on the past 8 years of stock performance.
CRISPR Therapeutics AG Stock Rating
Sell
11
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG overpriced?
-
CRISPR Therapeutics AG has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
CRISPR Therapeutics AG Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crisprtx.com
52-Week Data
52-Week High:
91.10
52-Week Low:
36.52
Prediction Charts
Market Cap:
3.5B
Price in USD:
40.53
Volume:
1.4M
Beta:
2.02
Technical Analysis
SMA50:
45.65
SMA100:
46.44
SMA200:
51.21
52-Wk Change:
-33.4%
Stock Predictions
-
Is CRISPR Therapeutics AG stock public?Yes, CRISPR Therapeutics AG is a publicly traded company.
-
What is the CRISPR Therapeutics AG stock quote today?The CRISPR Therapeutics AG stock price is 40.53 USD today.
-
How to buy CRISPR Therapeutics AG stock online?You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-27 | 40.76 | 40.02 | 41.14 | 39.85 |
| Dec-30 | 39.55 | 38.65 | 39.67 | 38.20 |
| Dec-31 | 39.00 | 39.36 | 39.69 | 38.75 |
| Jan-2 | 39.81 | 41.43 | 41.44 | 39.34 |
| Jan-3 | 41.50 | 41.02 | 42.09 | 40.70 |
| Jan-6 | 41.25 | 42.43 | 44.28 | 41.21 |
| Jan-7 | 42.92 | 41.92 | 44.12 | 41.66 |
| Jan-8 | 41.56 | 41.29 | 41.73 | 40.55 |
| Jan-10 | 40.04 | 39.69 | 40.37 | 38.51 |
| Jan-13 | 39.06 | 38.85 | 39.20 | 36.52 |
| Jan-14 | 39.62 | 38.36 | 40.20 | 38.21 |
| Jan-15 | 39.88 | 39.04 | 40.99 | 38.89 |
| Jan-16 | 39.76 | 40.30 | 40.68 | 39.44 |
| Jan-17 | 41.00 | 40.53 | 41.55 | 40.45 |
CRISPR Therapeutics AG Earnings
CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.
CRISPR Therapeutics AG Forecast Revenue Growth
CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $2.12 per share.
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.